FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 269

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
BLRX Nasdaq BioLineRx Ltd. 2830
BLTE Nasdaq Belite Bio, Inc 2830
BMEA Nasdaq Biomea Fusion, Inc. 2830
CADL Nasdaq Candel Therapeutics, Inc. 2830
CAI Nasdaq Caris Life Sciences, Inc. 2830
CANF NYSE American Can-Fite BioPharma Ltd. 2830
CARM Nasdaq Carisma Therapeutics, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq Conduit Pharmaceuticals Inc. 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEM Nasdaq Cullinan Therapeutics, Inc. 2830
CGEN Nasdaq Compugen Ltd. 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CHRS Nasdaq Coherus Oncology, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CNTA Nasdaq Centessa Pharmaceuticals plc 2830
COEP Nasdaq Coeptis Therapeutics Holdings, Inc. 2830
COGT Nasdaq Cogent Biosciences, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CRL New York Charles River Laboratories International 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CSCI Nasdaq COSCIENS Biopharma Inc. 2830
CUPR Nasdaq Cuprina Holdings (Cayman) Limited 2830
DERM Nasdaq Journey Medical Corporation 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRMA Nasdaq Dermata Therapeutics, Inc. 2830
DRTS Nasdaq Alpha Tau Medical Ltd. 2830
DSNKY Over the counter Daiichi Sankyo Company, Limited 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
DYAI Nasdaq Dyadic International, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
EDIT Nasdaq Editas Medicine, Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ELTX Nasdaq Elicio Therapeutics, Inc. 2830
ENLV Nasdaq Enlivex Therapeutics Ltd. 2830
ENSC Nasdaq Ensysce Biosciences, Inc. 2830
ENTO Nasdaq Entero Therapeutics, Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
EQ Nasdaq Equillium, Inc. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
EVGN Nasdaq Evogene Ltd. 2830
EVO Nasdaq Evotec SE 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
FBLG Nasdaq FibroBiologics, Inc. 2830
FGEN Nasdaq FibroGen, Inc. 2830
Results 50 through 100 of 269